NYSE ARCA | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.78% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.06% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 4.04% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 4.03% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.00% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.82% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.80% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 3.67% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.58% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.56% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.50% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.41% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.39% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.37% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 3.36% |